Determination of diuretics in human urine using HPLC coupled with magnetic solid-phase extraction based on a metal-organic framework

Biomed Chromatogr. 2020 Sep;34(9):e4876. doi: 10.1002/bmc.4876. Epub 2020 May 26.

Abstract

Magnetic solid-phase extraction (MSPE) employing a metal-organic framework (Fe3 O4 @UiO-66-OH) combined with high-performance liquid chromatography was developed for the determination of trace diuretics in urine. The structure and properties of Fe3 O4 @UiO-66-OH were investigated using X-ray diffraction, infrared spectroscopy, scanning electron microscopy and vibrating sample magnetometry. Magnetic solid-phase extraction conditions, such as adsorbent amount and solution pH, were optimized using response surface methodology. Under the optimal conditions, the method resulted in excellent linearity with a high correlation coefficient (r > 0.99), satisfactory intraday repeatability (1.78-2.99%), low limits of detection (0.08-0.23 ng/ml), and good recoveries in urine samples (between 93.5 and 103%). Fe3 O4 @UiO-66-OH based on MSPE is a novel pretreatment technique for the detection of trace diuretics in urine.

Keywords: Box-Behnken design; diuretics; high-performance liquid chromatography; magnetic solid phase extraction; metal-organic framework.

MeSH terms

  • Chromatography, High Pressure Liquid / methods*
  • Diuretics / urine*
  • Ferric Compounds / chemistry
  • Humans
  • Limit of Detection
  • Linear Models
  • Metal-Organic Frameworks / chemistry*
  • Organometallic Compounds / chemistry
  • Phthalic Acids / chemistry
  • Reproducibility of Results
  • Solid Phase Extraction / methods*

Substances

  • Diuretics
  • Ferric Compounds
  • Metal-Organic Frameworks
  • Organometallic Compounds
  • Phthalic Acids
  • UiO-66
  • ferric oxide